ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Copeland, J. G.
Right arrow Articles by Sethi, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Copeland, J. G., 3rd
Right arrow Articles by Sethi, G. K.

The Annals of Thoracic Surgery, Vol 58, 630-637, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Four-year experience with the CarboMedics valve: the North American experience. North American team of clinical investigators for the CarboMedics prosthetic heart valve

JG Copeland 3rd and GK Sethi
University of Arizona Health Sciences Center, Tucson.

A multicenter prospective trial of the CarboMedics valve was initiated in July 1988. Twelve North American centers were included for the purpose of establishing the safety and efficacy of this new rotatable, bileaflet, pyrolytic-Carbon prosthesis. The study included 786 patients (using 891 valves) enrolled between July 1988 and August 1992. There were 447 male and 339 female patients from ages 2 to 83 years. Of the 618 primary replacement operations (including double valves), 393 were aortic and 292 were mitral valve replacements. Mean follow-up time was 16.1 months; 94.7% of patients had completed documentation up to and including one year. New York Heart Association functional class was III or IV for 84.4% of patients preoperatively, and I and II in over 96% of patients for the first three postoperative years. Survival for the entire group was 93% (622) at 1 month, 89% (504) at 1 year, 87% (213) at 2 years, and 85% (41) at 3 years. There were no significant survival differences between primary and repeat replacements or between aortic, mitral, and double-valve replacements. Primary replacement patients with concomitant procedures (n = 241) had slightly decreased survival rates compared with those who underwent isolated procedures (isolated survival rate, 92% [98]; concomitant procedure survival rate, 81% [59] at 2 years; p = 0.002). There was no valve failure. Linearized rates (events per 100 patient-years) in primary replacement patients after 30 days included the following: thrombosis, 0.39; thromboembolism, 0.92; hemolysis, 0.53; anticoagulant-related hemorrhage, 2.36; paravalvular leak, 0.92; endocarditis, 0.53; reoperation, 0.92; and explantation, 0.66.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Card Surg AdultHome page
T. Gudbjartsson, T. Absi, and S. Aranki
Mitral Valve Replacement
Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
C. H. Kang, H. Ahn, K. H. Kim, and K.-B. Kim
Long-Term Result of 1144 CarboMedics Mechanical Valve Implantations
Ann. Thorac. Surg., June 1, 2005; 79(6): 1939 - 1944.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
T. Gudbjartsson, S. Aranki, and L. H. Cohn
Mechanical/Bioprosthetic Mitral Valve Replacement
Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
M. Carrier, M. Pellerin, L. P. Perrault, P. Page, Y. Hebert, R. Cartier, I. Dyrda, and L. C. Pelletier
Aortic valve replacement with mechanical and biologic prostheses in middle-aged patients
Ann. Thorac. Surg., May 1, 2001; 71 (2007): S253 - S256.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. J.R. Dalrymple-Hay, R. Pearce, S. Dawkins, M. P. Haw, R. K. Lamb, S. A. Livesey, and J. L. Monro
A single-center experience with 1,378 CarboMedics mechanical valve implants
Ann. Thorac. Surg., February 1, 2000; 69(2): 457 - 463.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. G. Copeland, F. A. Arabia, R. G. Smith, G. K. Sethi, P. E. Nolan, and M. E. Banchy
Arizona experience with CardioWest total artificial heart bridge to transplantation
Ann. Thorac. Surg., August 1, 1999; 68(2): 756 - 760.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W.R. E. Jamieson, R. T. Miyagishima, G. L. Grunkemeier, E. Germann, C. Henderson, G. J. Fradet, L. H. Burr, and S. V. Lichtenstein
Bileaflet mechanical prostheses performance in mitral position
Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Bernal, R. Martin-Duran, J. M. Rabasa, and J. M. Revuelta
The CarboMedics ""Top-Hat"" supraannular prosthesis
Ann. Thorac. Surg., May 1, 1999; 67(5): 1299 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Bernal, J. M. Rabasa, F. Gutierrez-Garcia, C. Morales, J. F. Nistal, and J. M. Revuelta
The CarboMedics Valve: Experience With 1,049 Implants
Ann. Thorac. Surg., January 1, 1998; 65(1): 137 - 143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.